41 results
Page 2 of 3
20-F/A
EX-4.38
rml0qsa hg
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
9gi31
23 Mar 15
Annual report (foreign) (amended)
12:00am
6-K
EX-99.1
dbnm8yhqseo ft
5 Mar 15
Current report (foreign)
12:00am
6-K
EX-99
zp9wwi3v b36jmikl4
24 Dec 14
Current report (foreign)
12:00am
6-K
EX-1.1
59scnwoc6ep4 yosy6w
30 May 14
Current report (foreign)
12:00am
6-K
EX-99.1
oah9tj gbr83
3 Mar 14
Current report (foreign)
12:00am
424B3
4rmyi3nh9x
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-10.1
yufeev
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
424B3
ye6ia8t4lk7ahn3ydg
15 Oct 12
Prospectus supplement
12:00am
F-1
ywy0a1ma7d vij3v
2 Oct 12
Registration statement (foreign)
12:00am
6-K
EX-99
mggqc6hlephpwq1jwv1q
27 Sep 12
Current report (foreign)
12:00am
424B3
3g2mzwn
28 Mar 12
Prospectus supplement
12:00am
20-F
uwln1y n3fio5
22 Mar 12
Annual report (foreign)
12:00am
6-K
EX-99.2
sdc1kddk75y0xlhcs1
16 Feb 12
Current Report, Foreign Issuer
12:00am
20FR12B/A
dltk48q4yzjii3t3o
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
43mi5em7
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am